Era7 Receives $430K Grant
News Jan 13, 2016
The ministry of Industry through their Agency CDTI has granted $1 M to the consortium CARDIOBIOME in which Era7 Bioinformatics has the task of developing a cloud based bioinformatics platform for the analysis of 16S data from human microbiomes and for facilitating the integration with EHR (Electronic Health Record) following standards like HL7, FHIR and SMART.
The Project will be focused on Acute Myocardial Infarction as proof of concept and more than 4000 samples from patients will be sequenced. “This new research and development project will be a new impulse for getting our goal: to be an international reference for 16S metagenomics, especially for microbiome projects” declared Dr. Eduardo Pareja, CEO of Era7. “The general interest in getting genomics data integrated with health care pipelines and EHR should be complemented with the integration of 16S metagenomics results since these results will be very important as useful biomarkers for prevention, diagnosis and follow-up of many diseases. In Era7, we are convinced that Precision Medicine will incorporate in the EHR 16S data from different microbiomes: oral, gut, blood, skin, bronchial or from disease-specific regions as tumors or abscesses.” Added Eduardo Pareja.
Microbiome analysis is an exponentially growing application of NGS not only for human health studies but also for sectors such as animal and plant health, industry, biofuel or agrifood.
Habitat loss, habitat fragmentation and the loss of genetic diversity are the main factors driving the extinction of many wild species, and the few eastern massasauga rattlesnakes remaining in Illinois have certainly suffered two of the three. A long-term study of these snakes reveals, however, that – despite their alarming decline in numbers – they have retained a surprising amount of genetic diversity.READ MORE
Researchers have discovered a navigational gene in glass catfish called the electromagnetic-perceptive gene, or EPG, that responds to certain magnetic waves. These findings have the potential to revolutionize treatments for humans and help those who suffer from tremors related to Parkinson’s and seizures associated with epilepsy.